[go: up one dir, main page]

ZA200206654B - Monoclonal antibodies to the human LDL receptor, their production and use. - Google Patents

Monoclonal antibodies to the human LDL receptor, their production and use. Download PDF

Info

Publication number
ZA200206654B
ZA200206654B ZA200206654A ZA200206654A ZA200206654B ZA 200206654 B ZA200206654 B ZA 200206654B ZA 200206654 A ZA200206654 A ZA 200206654A ZA 200206654 A ZA200206654 A ZA 200206654A ZA 200206654 B ZA200206654 B ZA 200206654B
Authority
ZA
South Africa
Prior art keywords
clone
monoclonal antibodies
antibody
ldlr
hybridoma
Prior art date
Application number
ZA200206654A
Other languages
English (en)
Inventor
Nachum Yonah
Dany Suissa
Ilana Belzer
Antonetti Francesco
Smolarsky Moshe
Michel Dreano
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26323933&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200206654(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL13502500A external-priority patent/IL135025A0/xx
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ZA200206654B publication Critical patent/ZA200206654B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200206654A 2000-03-13 2002-08-20 Monoclonal antibodies to the human LDL receptor, their production and use. ZA200206654B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13502500A IL135025A0 (en) 2000-03-13 2000-03-13 Monoclonal antibodies to the human ldl receptor, their production and use
IL13921700A IL139217A0 (en) 2000-03-13 2000-10-23 Monoclonal antibodies to the human ldl receptor, their production and use
PCT/IL2001/000216 WO2001068710A1 (en) 2000-03-13 2001-03-08 Monoclonal antibodies to the human ldl receptor, their production and use

Publications (1)

Publication Number Publication Date
ZA200206654B true ZA200206654B (en) 2003-10-20

Family

ID=26323933

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200206654A ZA200206654B (en) 2000-03-13 2002-08-20 Monoclonal antibodies to the human LDL receptor, their production and use.

Country Status (33)

Country Link
US (1) US6849720B2 (pl)
EP (1) EP1263790B1 (pl)
JP (1) JP4768193B2 (pl)
KR (1) KR100882081B1 (pl)
CN (1) CN1418225B (pl)
AR (1) AR028518A1 (pl)
AT (1) ATE362490T1 (pl)
AU (2) AU2001241002B8 (pl)
BG (1) BG65762B1 (pl)
BR (1) BR0109164A (pl)
CA (1) CA2402593C (pl)
CY (1) CY1108020T1 (pl)
CZ (1) CZ20023098A3 (pl)
DE (1) DE60128452T2 (pl)
DK (1) DK1263790T3 (pl)
EA (1) EA007494B1 (pl)
EE (1) EE200200517A (pl)
ES (1) ES2282238T3 (pl)
HK (1) HK1055750A1 (pl)
HR (1) HRP20020704B1 (pl)
HU (1) HU226194B1 (pl)
IL (2) IL139217A0 (pl)
MX (1) MXPA02009091A (pl)
NO (1) NO330904B1 (pl)
NZ (1) NZ520944A (pl)
PL (1) PL206041B1 (pl)
PT (1) PT1263790E (pl)
RS (1) RS51406B (pl)
SI (1) SI1263790T1 (pl)
SK (1) SK287348B6 (pl)
UA (1) UA78489C2 (pl)
WO (1) WO2001068710A1 (pl)
ZA (1) ZA200206654B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114629D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Method
WO2004111652A1 (en) 2003-06-19 2004-12-23 Applied Research Systems Ars Holding N.V. Use of prion conversion modulating agents
FR2889533B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
FR2889532B1 (fr) * 2005-08-03 2007-10-12 Lab Francais Du Fractionnement Anticorps diriges contre le recepteur du ldl
WO2007094027A2 (en) * 2006-02-17 2007-08-23 Paolo La Colla Methods for the diagnosis of proliferative and/or conformational diseases
FR2910896B1 (fr) * 2006-12-29 2012-11-16 Lab Francais Du Fractionnement Anticorps monoclonal dirige contre le recepteur humain des ldl
IL182956A0 (en) 2007-05-03 2008-01-20 Yeda Res & Dev Glycan modified soluble receptors and binding proteins and their use
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
GB0922377D0 (en) * 2009-12-22 2010-02-03 Arab Gulf University The Mutant LDL receptor
WO2011147863A1 (en) 2010-05-25 2011-12-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024155A1 (en) 2011-08-17 2013-02-21 Inserm (Institut National De La Sante Et De La Recherche Medicale) Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024157A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of host targeting agents for the treatment and the prevention of hcv infection
CN103111270B (zh) * 2013-02-26 2015-06-10 王业富 一种乙型肝炎抗原蛋白的吸附材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182364A (en) * 1990-02-26 1993-01-26 The Scripps Research Institute Polypeptide analogs of apolipoprotein E
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
US5945308A (en) * 1998-04-03 1999-08-31 Incyte Pharmaceuticals, Inc. Human oxidized LDL receptor
JP2000279174A (ja) * 1999-03-30 2000-10-10 Bml Inc ヒトｌｄｌレセプターに対するモノクローナル抗体及びこれを用いる家族性高脂血症の判定方法

Also Published As

Publication number Publication date
IL151713A0 (en) 2003-04-10
JP4768193B2 (ja) 2011-09-07
JP2004506603A (ja) 2004-03-04
ES2282238T3 (es) 2007-10-16
AR028518A1 (es) 2003-05-14
SK13122002A3 (sk) 2003-04-01
HRP20020704A2 (en) 2004-12-31
SK287348B6 (sk) 2010-08-09
CY1108020T1 (el) 2013-09-04
SI1263790T1 (sl) 2007-10-31
HK1055750A1 (en) 2004-01-21
WO2001068710A1 (en) 2001-09-20
EA007494B1 (ru) 2006-10-27
NZ520944A (en) 2004-04-30
CN1418225A (zh) 2003-05-14
NO20024223L (no) 2002-10-24
EP1263790B1 (en) 2007-05-16
PT1263790E (pt) 2007-06-01
DE60128452T2 (de) 2007-09-13
EA200200974A1 (ru) 2003-02-27
EE200200517A (et) 2004-02-16
HRP20020704B1 (en) 2011-01-31
KR20020089384A (ko) 2002-11-29
EP1263790A1 (en) 2002-12-11
CA2402593C (en) 2012-07-03
BG107063A (bg) 2003-05-30
AU4100201A (en) 2001-09-24
US6849720B2 (en) 2005-02-01
YU68602A (sh) 2006-03-03
DK1263790T3 (da) 2007-07-02
UA78489C2 (en) 2007-04-10
IL139217A0 (en) 2001-11-25
CN1418225B (zh) 2012-04-18
US20030186343A1 (en) 2003-10-02
MXPA02009091A (es) 2005-06-20
HU226194B1 (hu) 2008-06-30
DE60128452D1 (de) 2007-06-28
CA2402593A1 (en) 2001-09-20
BG65762B1 (bg) 2009-10-30
NO20024223D0 (no) 2002-09-04
HUP0300142A3 (en) 2005-07-28
HUP0300142A2 (hu) 2003-06-28
BR0109164A (pt) 2002-11-26
KR100882081B1 (ko) 2009-02-10
PL358381A1 (pl) 2004-08-09
ATE362490T1 (de) 2007-06-15
PL206041B1 (pl) 2010-06-30
AU2001241002B8 (en) 2006-05-04
NO330904B1 (no) 2011-08-15
AU2001241002B2 (en) 2006-04-06
RS51406B (sr) 2011-02-28
CZ20023098A3 (cs) 2003-02-12

Similar Documents

Publication Publication Date Title
US7541438B2 (en) Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
US5801142A (en) Human mts-1 protein
CA2402593C (en) Monoclonal antibodies to the human ldl receptor, their production and use
US5565354A (en) Production of human monoclonal antibodies specific for hepatitis B surface antigen
WO1994022478A1 (en) PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU)
AU2001241002A1 (en) Monoclonal antibodies to the human LDL receptor, their production and use
EP0396505A2 (en) Monoclonal antibodies specific for an immunoglobulin isotype
KR100244573B1 (ko) 사람 유래 씨이티피에 반응성을 갖은 모노클로날 항체 및 사람 유래 씨이티피의 정량방법
US5030564A (en) Monoclonal antibody specific to the lymphokine LK 2 and its method of production
CA1231067A (en) Monoclonal antibody to peroxidase and hybridoma producing it
JP3580948B2 (ja) ヒト由来ｃｅｔｐに反応性を有するモノクローナル抗体及びヒト由来ｃｅｔｐの定量方法
KR0140365B1 (ko) 콜레스테롤 에스터라제를 특이적으로 인지하는 단세포군 항체와 이를 분비하는 융합세포주
EP0278160A2 (en) Human monoclonal anti cancer antibodies, hybridoma cell lines producing them and their uses
GB2175918A (en) Monoclonal antibodies
JPH1121300A (ja) 抗ヒトトランスフェリンモノクローナル抗体及びこれを産生するハイブリドーマ細胞株
WO1999006555A1 (fr) Nouvelle proteine humaine mmp-20 et son utilisation